GlassScriptPhysician profile
Sean W Ericson
NPI 1265860233
$5,540.92
in general payments reported to CMS, 2019-2025
9 companies · $9.71 in 2025
The $9.71 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $612 · 2021: $385 · 2022: $1,464 · 2023: $1,791 · 2024: $1,280 · 2025: $9.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,983 · Food and Beverage: $1,073 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,982.74 |
| Food and Beverage | $1,073.03 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $2,250.00 | 2022-2024 | |
| Dentsply Sirona INC | $2,113.10 | 2020-2024 | |
| A-Dec, INC. | $985.00 | 2020-2021 | |
| Align Technology, INC. | $75.00 | 2022-2023 | Invisalign, Itero |
| Envista Holdings Corporation | $41.25 | 2024 | Endodontics |
| Nobel Biocare USA | $32.75 | 2022-2023 | Nobelactive |
| Kerr Corporation | $19.20 | 2023 | Files |
| 3m Company | $14.91 | 2023 | 3m Filtek |
| Voco America INC. | $9.71 | 2025 | Meron Plus Qm, Grandio So, Admira Fusion X-Tra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Ericson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.